Daily News Podcast

Bisphosphonate holiday reduces risk of atypical femur fracture

Publish date: October 10, 2018

 

A holiday from bisphosphonates may help reduce atypical femur fracture risk. Also today, most dermatologic drugs are safe for breastfeeding mothers, impressive HbA1c and weight control from a new novel drug, and short-term NSAIDs appear safe for high-risk patients.

Recommended Reading

Experts advocate for flu vaccination
MDedge Neurology
New and Noteworthy Information—October 2018
MDedge Neurology
Get on top of home BP monitoring
MDedge Neurology
Aspirin for the elderly: what to do
MDedge Neurology
Neurological disease and aging
MDedge Neurology
PCV13 for older adults
MDedge Neurology
Sexual assault, harassment linked to depression
MDedge Neurology
FDA approves new treatment for hereditary transthyretin-mediated amyloidosis
MDedge Neurology
9-valent HPV vaccine approved for 27-45 age group
MDedge Neurology
Outpatients antibiotics and disease codes
MDedge Neurology